SEC 13F Intelligence

Managers / Q1 2020 · view latest →

Telemetry Investments, L.L.C.

CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700

Reported Value
$29M
Q1 2020
Positions
54
Filings on Record
17
2019–present window
Filed
May 15, 2020
original filing

Summary

Telemetry Investments, L.L.C. reported $29M in U.S.-listed holdings across 54 positions for Q1 2020.

Its largest position, Allergan, represents 11.6% of the portfolio.

Compared with Q4 2019, the fund opened 21 new positions and exited 14.

Portfolio Metrics

Turnover
+47.6%
vs prior filed quarter
Top-10 Concentration
+43.5%
share of reported value
Largest Position
+11.6%
Allergan
New / Exited
21 / 14
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $157MQ4 ’18Q1 ’19: $197MQ2 ’19: $129MQ2 ’19Q3 ’19: $35MQ4 ’19: $30MQ4 ’19Q1 ’20: $29MQ2 ’20: $37MQ2 ’20Q3 ’20: $46MQ4 ’20: $59MQ4 ’20Q1 ’21: $88MQ2 ’21: $73MQ2 ’21Q3 ’21: $74MQ4 ’21: $78MQ4 ’21Q1 ’22: $63MQ2 ’22: $84MQ2 ’22Q3 ’22: $78Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 70.7%Other: 22.3%ETP: 5.9%ADR: 0.8%REIT: 0.3%
  • Common Stock · 70.7% · $20M
  • Other · 22.3% · $6M
  • ETP · 5.9% · $2M
  • ADR · 0.8% · $242,000
  • REIT · 0.3% · $81,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DISDISNEY WALT CONEW+20.7K20.7K+$2M$2M
EXMOCEXXON MOBIL CORPNEW+48.6K48.6K+$2M$2M
LOGMEIN INCNEW+13.0K13.0K+$1M$1M
BACBK OF AMERICA CORPNEW+45.0K45.0K+$954,000$954,000
XLESELECT SECTOR SPDR TRNEW+30.0K30.0K+$872,000$872,000
WABCO HLDGS INCNEW+6.0K6.0K+$810,000$810,000
TIFFANY & CO NEWNEW+5.0K5.0K+$648,000$648,000
BELLEROPHON THERAPEUTICS INCNEW+50.0K50.0K+$548,000$548,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

47 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ALLERGAN PLCSHS11.57%$3M18.7K
2KDMNKADMON HLDGS INChistory →COM5.66%$2M386.6K
3ZOSANO PHARMA CORPCOM NEW5.12%$1M2.61M
4LOGMEIN INCCOM3.78%$1M13.0K
5EIGER BIOPHARMACEUTICALS INCCOM3.36%$961,000141.3K
6XLESELECT SECTOR SPDR TRhistory →ENERGY3.05%$872,00030.0K
7ADMAADMA BIOLOGICS INChistory →COM2.92%$837,000290.8K
8WABCO HLDGS INCCOM2.83%$810,0006.0K
9MELLANOX TECHNOLOGIES LTDSHS2.64%$755,0006.2K
10SPRINT CORPORATIONCOM2.56%$734,00085.1K
11RA PHARMACEUTICALS INCCOM2.51%$720,00015.0K
12ACIAACACIA COMMUNICATIONS INChistory →COM2.35%$672,00010.0K
13DISDISNEY WALT COhistory →COM DISNEY2.33%$667,0006.9K
14FITBIT INCCL A2.33%$666,000100.0K
15GLDSPDR GOLD TRUSThistory →GOLD SHS2.33%$666,0004.5K
16TIFFANY & CO NEWCOM2.26%$648,0005.0K
17EXMOCEXXON MOBIL CORPhistory →COM2.15%$615,00016.2K
18KEMET CORPCOM NEW2.04%$583,00024.1K
19VRAYQVIEWRAY INChistory →COM1.92%$549,000219.5K
20BELLEROPHON THERAPEUTICS INCCOM NEW1.91%$548,00050.0K
21TECH DATA CORPCOM1.83%$523,0004.0K
22ACRSACLARIS THERAPEUTICS INChistory →COM1.82%$521,000501.0K
23AFFIMED N VCOM1.79%$512,000323.8K
24XTNTXTANT MED HLDGS INChistory →COM NEW1.76%$504,000752.6K
25TALLGRASS ENERGY LPCLASS A SHS1.47%$420,00025.5K
26ADSWADVANCED DISP SVCS INC DELhistory →COM1.37%$393,00012.0K
27WRIGHT MED GROUP N VORD SHS1.25%$358,00012.5K
28GLOBALSTAR INCCOM1.25%$358,0001.22M
29RIGEL PHARMACEUTICALS INCCOM NEW1.23%$352,000225.5K
30NEMNEWMONT CORPhistory →COM1.13%$324,0007.2K
31BACBK OF AMERICA CORPhistory →COM1.11%$318,00015.0K
32VERASTEM INCCOM1.08%$308,000116.8K
33FORTY SEVEN INCCOM1.00%$286,0003.0K
34OMNOVA SOLUTIONS INCCOM0.85%$244,00024.1K
35SANBANCO SANTANDER SAADR0.61%$176,00075.0K
36CRAFT BREW ALLIANCE INCCOM0.54%$156,00010.5K
37MUSTANG BIO INCCOM0.53%$152,00056.7K
38VANECK VECTORS ETF TROIL SVCS ETF0.49%$141,00035.0K
39STEMLINE THERAPEUTICS INCCOM0.39%$112,00023.1K
40TRACON PHARMACEUTICALS INCCOM NEW0.39%$111,00066.4K
41CENTRAL EUROPEAN MEDIA ENTRPCL A NEW0.36%$104,00033.2K
42CONDOR HOSPITALITY TR INCCOM NEW0.28%$81,00019.7K
43PBRPETROLEO BRASILEIRO SA PETROSPONSORED ADR0.23%$66,00012.0K
44ENDOLOGIX INCCOM NEW0.19%$54,00078.5K
45FORTRESS BIOTECH INCCOM0.14%$39,00020.4K
46ROSEHILL RES INCCL A · *W EXP 04/27/2020.10%$28,000124.4K
47STEIN MART INCCOM0.02%$5,00010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2022Under review146Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$78M177Nov 17, 202213F-HRchanges · EDGAR ↗
Q2 2022$84M177Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$63M165May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$78M178Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$74M160Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$73M139Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$88M126May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$59M89Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$46M73Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$37M65Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$29M54May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$30M41Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$35M53Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$129M82Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$197M101May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$157M136Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.